News Agency
Men's Weekly

NK CellTech Announces FDA Clearance for Clinical Trial of NK010

  • Written by PR Newswire

SHANGHAI, Jan. 22, 2024 /PRNewswire/ -- On January 17, 2024, NK CellTech Co., Ltd. (NK CellTech), a leading biotech company focused on the development of NK cellular therapies, is pleased to announce that the FDA has granted clearance for the clinical trial of NK010, the non-genetically modified natural killer cells. NK010 is the first...

Read more: NK CellTech Announces FDA Clearance for Clinical Trial of NK010

Steps to Take When Facing a Commercial Lease Dispute in Australia

A commercial lease dispute can disrupt business operations, especially when the business premises are central to generating revenue. This article outlines practical steps to take when a disagreement arises under a commercial lease in Australia and how, as a tenant, you can... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion